Electrical Stimulation of the Mandibular Nerve for Pain and Function Management in Temporomandibular Disorders

Launched by ORIGENKINESIS FISIOTERAPIA · Feb 10, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help people with Temporomandibular Disorders (TMD), which can cause pain and difficulty moving the jaw. The researchers want to see if a treatment called percutaneous electrical nerve stimulation (PENS) can help relieve pain and improve jaw function by targeting a specific nerve in the jaw area. TMD affects many people, and for some, the pain can be intense and affect daily activities like eating and talking.

To participate in this study, you need to be between the ages of 18 and 65 and have certain types of jaw pain related to TMD. You should have limited mouth opening and no significant health issues that could interfere with the study. Participants will receive treatment and will be monitored for any changes in their pain and jaw function. This study is still in the planning stage and is not yet recruiting participants, but it could offer new hope for those struggling with TMD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with local myofascial pain and/or increased tension in the masticatory muscles.
• • Patients with myofascial pain from temporomandibular disorder (TMD) at the time, diagnosed according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).
• • Absence of temporomandibular disc displacement with or without reduction.
• • Pain in the masticatory muscles associated with limited mouth opening (\<40mm).
• • Good general health (absence of chronic diseases that may affect the temporomandibular joint or masticatory muscles).
• • Written consent to participate in the study.
• Exclusion Criteria:
• • Injury to the face or head during the research participation.
• • Undergone surgical procedures performed in the craniocervical region and degenerative neurological diseases.
• • Sudden illness of the patient that prevented participation in the study.
• • Will to end participation in the study.
• • Less than 2 weeks of evolution.
• • Inability to understand instructions or sign the informed consent.
• • Minor patients.
• • Regular medication, such as muscle relaxants, anticonvulsants, antidepressants, or anxiolytics
• • Facial paralysis.
• • Presenting a disease or infectious/inflammatory process of dental origin.